Image: Photographee.eu
A new study published in Frontiers in Aging found that a combination of high-dose vitamin D, omega-3s, and a simple home strength exercise program (SHEP) showed a cumulative reduction by 61% in cancer risk in healthy adults aged 70 or older. It is the first study to test the combined benefit of three affordable public health interventions for the prevention of invasive cancers. Following future studies, the results may impact the future of cancer prevention in older adults.
Cancer is considered a major age-related disease in Europe and the US. It is the second leading cause of mortality in older adults and the chances of getting most cancers increases with age.
Apart from preventative recommendations such as not smoking and sun protection, public health efforts that focus on cancer prevention are limited, according to Dr Heike Bischoff-Ferrari of the University Hospital Zurich: “Preventive efforts in middle-aged and older adults today are largely limited to screening and vaccination efforts.”
Vitamin D, omega-3, and exercise
Mechanistic studies have shown that vitamin D inhibits the growth of cancer cells. Similarly, omega-3 may inhibit the transformation of normal cells into cancer cells, and exercise has been shown to improve immune function and decrease inflammation, which may help in the prevention of cancer.
However, there was a lack of robust clinical studies proving the effectiveness of these three simple interventions, alone or combined.
Bischoff-Ferrari and her colleagues wanted to fill these knowledge gaps by testing the effect of daily high-dose vitamin D3 (one form of vitamin D supplements), daily supplemental omega-3s, and a simple home exercise program, alone and in combination, on the risk of invasive cancer among adults aged 70 or older.
A combination of simple treatments
To do so, the researchers conducted the DO-HEALTH trial: a three-year trial in five European countries (Switzerland, France, Germany, Austria, and Portugal) with 2,157 participants.
“In DO-HEALTH, our aim was to test promising combined interventions for cancer prevention taking advantage of potentially small additive benefits from several public health strategies,” explained Bischoff-Ferrari. “In fact, novel cancer treatments aim to block multiple pathways for cancer development by combining several agents. We translated this concept into cancer prevention.”
The participants were randomized into eight different groups to test the individual and combined benefit of the interventions: group one received 2,000 IU per day of Vitamin D3 (equivalent to > 200% the amount of current recommendations for older adults, which is 800 IU per day), 1g per day of omega-3s, and three times per week SHEP; group two vitamin D3 and omega-3s; group three vitamin D3 and SHEP; group four omega-3s and SHEP; group five vitamin D3 alone; group six omega-3s alone; group seven SHEP alone; and the last group received a placebo.
Participants received check-up phone calls every three months and had standardized examinations of health and function in the trial centers at baseline, year one, year two, and year three.
Preventing invasive cancer
The results show that all three treatments (vitamin D3, omega-3s, and SHEP) had cumulative benefits on the risk of invasive cancers.
Each of the treatments had a small individual benefit but when all three treatments were combined, the benefits became statistically significant, and the researchers saw an overall reduction in cancer risk by 61%.
“This is the first randomized controlled trial to show that the combination daily vitamin D3, supplemental marine omega-3s, and a simple home exercise program may be effective in the prevention of invasive cancer among generally healthy and active adults aged 70 and older,” Bischoff-Ferrari commented.
The results may impact the future of invasive cancer prevention in older adults. Bischoff-Ferrari concluded: “Our results, although based on multiple comparisons and requiring replication, may prove to be beneficial for reducing the burden of cancer.”
“Future studies should verify the benefit of combined treatments in the prevention of cancer, also extending to longer follow-ups beyond the three-year duration assessed in this trial.”
Original Article: A combination of three simple treatments may reduce invasive cancer risk by 61% among adults aged 70+
More from: University Hospital of Zürich
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Invasive cancer risk
- “Here’s How I Knew I Had Prostate Cancer”: One Patient’s Story of Abruptly Elevated Markers
The prostate is a small gland located in the male reproductive system that's essential for producing seminal fluid. When it's healthy, the prostate is shaped similarly to a walnut, but prostate cancer ...
- Most BCG-Unresponsive Bladder Cancer Responds to TAR-200 Treatment
A novel delivery system of gemcitabine called TAR-200 led to promising responses in certain patients with non-muscle-invasive bladder cancer. A new delivery system of gemcitabine called TAR-200 ...
- Study sheds light on cancer cell 'tug-of-war'
Understanding how cancerous cells spread from a primary tumor is important for any number of reasons, including determining the aggressiveness of the disease itself. The movement of cells into the ...
- Voiding Dysfunction Common Among Patients With Nonmuscle-Invasive Bladder Cancer
Patients with concomitant congestive heart failure or sleep apnea were more likely to experience voiding dysfunction after NMIBC treatment.
- Spotlight on Bladder Cancer Developments at 2024 AUA Annual Meeting
The American Urological Association Annual Meeting took place May 3-6, 2024, in San Antonio, Texas, where data across the field of urologic oncology were presented.
Go deeper with Google Headlines on:
Invasive cancer risk
[google_news title=”” keyword=”invasive cancer risk” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Preventing invasive cancer
- Everything to know about the new breast cancer screening guidelines for women 40+
New recommendations from the US Preventive Services Task Force suggest that women 40 and older now should receive a mammogram every other year until the age of 74. Biennial mammograms had previously ...
- Why Didn't Doctors Caution Patients About the Link Between Hormone Replacement Therapy and Cancer?
For years, estrogen therapy was-and continues to be-prescribed as a treatment for women experiencing symptoms of menopause. Estrogen is a sex hormone found in both men and women (though in smaller ...
- No benefit of aspirin as adjuvant therapy in breast cancer patients: shows trial
USA: In a groundbreaking development in breast cancer treatment, the Alliance A011502 Randomized Trial has provided compelling evidence regarding the potential benefits of aspirin as adjuvant therapy.
- How investing in Cancer research now will save money in the long term
Based on the National Cancer Institute's (NCI) Surveillance Epidemiology and End Results (SEER), 1 in 2 men and 1 in 3 women will develop invasive cancer within their ... Errors can be harmful because ...
- Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
People with cancer may encounter checkpoint inhibitors as a treatment option but may not know where to start. This article can help you learn more.
Go deeper with Google Headlines on:
Preventing invasive cancer
[google_news title=”” keyword=”preventing invasive cancer” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]